Survival outcomes of neoadjuvant versus adjuvant therapy in patients with T1c, node‐negative, human epidermal growth factor receptor 2–positive breast cancer: A Surveillance, Epidemiology, and End Results population‐based study

Documenti analoghi

• Clinical Radiologic Analysis of 2964 Papillary Breast Lesions
  di: Hanyu Zhang, et al.
  Pubblicazione: (2024)
• Lnc‐TPT1‐AS1/CBP/ATIC Axis Mediated Purine Metabolism Activation Promotes Breast Cancer Progression
  di: Yiyun Zhang, et al.
  Pubblicazione: (2025)
• A fragile zero-watermarking method based on dual quaternion matrix decomposition
  di: Zhang, Mingcui, et al.
  Pubblicazione: (2025)
• An ultrasound‐based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation
  di: Qijun Zheng, et al.
  Pubblicazione: (2024)
• Implications of omitting sentinel lymph node biopsy on adjuvant decision making for patients with small breast cancers
  di: Kerollos Nashat Wanis, et al.
  Pubblicazione: (2025)